ENTX Entera Bio Corp: Nilai Akuntansi saben Saham

Logo grafis Entera Bio (ENTX)

Entera Bio Ltd. (ENTX) operates in the high-risk segment of developing oral hormone analogs without current sales. The change in BVPS reflects the dynamics of net equity per share, where this metric equals 0.15. Value growth is based on scaling the peptide delivery platform for osteoporosis, while potential is bolstered by B2B partnerships aimed at replacing injections with tablets.

Entera Bio Corp (ENTX): Nilai Buku Saham saka 04.07.2022 nganti 27.10.2026

Entera Bio Ltd - rincian analitis lan metrik utama (ENTX)

- rega lan prakiraan konsensus rega:
Kutipan saham Entera Bio Corp|ENTX - Rega prakiraan analis
- data kapitalisasi pasar:
Biji pasar Entera Bio Ltd.|ENTX - Nilai Bisnis
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Entera Bio|ENTX - Nilai Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku enterabio.com|ENTX - Nilai Agregat Aset
- data utang lan likuiditas:
Total Utang marang Modal Entera Bio Ltd.|ENTX - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Entera Bio Corp|ENTX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Entera Bio Ltd.
Pambiji fundamental perusahaan:enterabio.com - ENTX
Produk sing diprodhuksi Entera Bio Corp

Book value per share reflects the portion of equity attributable to a single security, allowing for the determination of the company's intrinsic value regardless of market volatility. By analyzing changes in BVPS, an investor can see how the capitalization of intellectual property rights for the ProNeura platform and patent protection sustain the fundamental stability of Entera Bio Ltd. (ENTX) in the face of generic competition.

Pesaing Entera Bio Ltd. (ENTX)

Nilai Akuntansi saben Saham Haleon Group HLN|Kenvue Health (KVUE) - Rega Buku Saham|Nilai Akuntansi saben Saham Verona Pharma plc|MENS (jyongbio.com) - Ekuitas saben Saham|Aset Bersih saben Siji Saham Ligand LGND|Nilai Buku Saham Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Nilai Buku saben Saham|Nilai Akuntansi Saham Alvotech Biopharmaceuticals (ALVO)|Nilai Buku saben Saham LQDA (Liquidia Corporation)|glpg.com - Nilai Buku saben Saham|Aset Bersih saben Siji Saham ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Nilai Akuntansi Saham|AMPH (Amphastar) - Aset Bersih saben Siji Saham|Pacira Corp (PCRX) - Nilai Akuntansi saben Saham|SPRY (ARS Pharmaceuticals) - Nilai Buku saben Saham|Nilai Buku saben Saham theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Nilai Akuntansi saben Saham|Nilai Akuntansi Saham SCPH (scpharmaceuticals.com)|TECX: Aset Bersih saben Siji Saham|TNXP - Nilai Aset Bersih saben Saham|Nilai Akuntansi saben Saham SXT China SXTC|EPRX - Rega Buku Saham|Nilai Buku saben Saham BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Nilai Akuntansi Saham|Nilai Buku saben Saham ORMP (Oramed)|Nilai Aset Bersih saben Saham HYFT|ABVC BioPharma (ABVC) - Aset Bersih saben Siji Saham|Nilai Akuntansi Saham cumberlandpharma.com (CPIX)|QNTM: Nilai Buku saben Saham|FibroGen Inc - Nilai Aset Bersih saben Saham|Telomir Pharma (TELO) - Aset Bersih saben Siji Saham|Rani Therapeutics (RANI) - Ekuitas saben Saham|SNYR - Nilai Akuntansi saben Saham|Rallybio (RLYB) - Rega Buku Saham|Nilai Buku saben Saham LEXX (Lexaria Bioscience Corp)|Nilai Aset Bersih saben Saham PULM|Pheton Holdings Ltd (PTHL) - Aset Bersih saben Siji Saham|Nilai Akuntansi Saham aptorumgroup.com (APM)|Nilai Buku saben Saham LYRA (Lyra Therapeutics, Inc.)|IBO - Nilai Buku saben Saham|Nilai Akuntansi saben Saham TNF Pharma (TNFA)|YCBD - Nilai Akuntansi Saham|PainReform Limited (PRFX) - Nilai Buku saben Saham|Altamira Therapeutics Ltd. (CYTO) - Aset Bersih saben Siji Saham|LIPO: Nilai Buku saben Saham|Aset Bersih saben Saham OPTN|Pieris Pharmaceuticals, Inc. - Aset Bersih saben Siji Saham|Nilai Aset Bersih saben Saham Procaps Group PROC|Nilai Akuntansi saben Saham Petros|Qilian International Corp - Nilai Akuntansi Saham|SLRN - Aset Bersih saben Siji Saham|tffpharma.com (TFFP) - Aset Bersih saben Siji Saham